Facebook
Twitter
LinkedIn
Forward
Incretin medications, like semaglutide and tirzepatide, suppress appetite and delay gastric emptying, facilitating weight loss and begging the question of the need for concurrent behavior change th
|
In this session, co-presented by a primary care and an obesity-focused tertiary care provider, we will review barriers and facilitators to pediatric obesity treatment in primary and tertiary care s
|
70% of Americans have pre-obesity or the serious, chronic, and relapsing disease of obesity.
|
This lecture explores the relationship between endocrine disruptors and their potential role in obesity.
|
Neurodiversity refers to the natural variation in neurological and cognitive function present in the human population.
|
The midlife stage in women is characterized by significant changes related to aging, menopause, and lifestyle.
|
The patient with inflammatory bowel disease (IBD), either Crohn's disease or ulcerative colitis, faces specific challenges in the management of obesity.
|
This session will include a discussion of how to diagnose and manage lipedema patients who also have obesity in conjunction with a plastic surgeon for the treatment of the disease to optimize outco
|
In this presentation Dr.
|
description hereThis presentation will enable clinicians to apply practical applications of cognitive behavioural therapy skills in obesity management.
|